06May 2023
Allergen Immunotherapy Enhances Airway Epithelial Antiviral Immunity in Allergic Asthma Patients

Allergen Immunotherapy Enhances Airway Epithelial Antiviral Immunity in Allergic Asthma Patients

This study investigated the effect of house dust mite sublingual immunotherapy (HDM-SLIT) on bronchial epithelial antiviral and inflammatory responses in patients with allergic asthma. The study found that HDM-SLIT improved bronchial epithelial antiviral resistance to viral infection by increasing the expression of IFN-β and IFN-λ genes and proteins. Proinflammatory cytokines IL-6 and TNF-α also increased in the HDM-SLIT group compared to baseline. The results suggest that the efficacy of HDM-SLIT in reducing exacerbations in allergic asthma may be explained by its ability to improve bronchial epithelial antiviral resistance.

  • #critical care

Like

Save

Share